רקורמון 2000 iu
roche pharmaceuticals (israel) ltd - epoetin beta 2000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative
רקורמון iu 3000
roche pharmaceuticals (israel) ltd - epoetin beta 3000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative
לונקווקס
abic marketing ltd, israel - lipegfilgrastim - תמיסה להזרקה - lipegfilgrastim 6 mg / 0.6 ml - lipegfilgrastim
סילדנאפיל טבע 100 מג
abic marketing ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 100 mg - sildenafil
סילדנאפיל טבע 25 מג
abic marketing ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 25 mg - sildenafil
סילדנאפיל טבע 50 מג
abic marketing ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 50 mg - sildenafil
מירסרה 30 מק"ג/0.3 מ"ל
roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 30 mcg/ml / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).
מירסרה 120 מק"ג/0.3 מ"ל
roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 120 mcg / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).
מירסרה 250 מק"ג/ 0.3 מ"ל
roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 250 mcg / 0.3 ml - solution for injection - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).
רווטיו
pfizer pfe pharmaceuticals israel ltd - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 20 mg - sildenafil - sildenafil - for adults > 18 years: treatment of primary pulmonary hypertension (pph) pulmonary hypertension (ph) associated with connective tissue disease (ctd) or ph following surgical repair at least 5 years previously of atrial septal defect (asd) ventricular septal defect (vsd) patent ductus arteriosus (pda) or aorto-pulmonary window.